Cost of two Russian anti-COVID vaccines to differ little – Vector Center director

TASS Russian News Agency | Nov 29, 2020 at 8:05 PM

MOSCOW, November 29. /TASS/. The cost of two Russian anti-coronavirus vaccines, Sputnik V and Epivaccorona, will be practically the same, Rinat Maksyutov, director general of Russia's Vector State Research Center of Virology and Biotechnology, the developer of one these vaccines, said on Sunday.

"According to information I have, based on calculation of the production facilities, the cost [of one dose of the Sputnik V and Epivaccorona vaccines] differs little," he said at an online Science Bar Hopping festival.

Two domestically-developed anti-coronavirus vaccines have been registered in Russia. One of them, Sputnik V, was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, the other one, Epivaccorona, was developed by the Vector Center. Another one, developed by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, is expected to be registered soon.

According to the Sputnik V's Twitter account and the Russian Direct Investment Fund, the investor in the vaccine development, one dose of the vaccine will cost at least 10 US dollars on international markets. Vaccination in Russia will be free of charge.

On March 11, 2020, the WHO declared the coronavirus outbreak a pandemic. According to the latest statistics, over 62.2 million people have been infected worldwide and more than 1.4 million deaths have been reported.

To date, 2,269,316 coronavirus cases have been confirmed in Russia, with 1,761,457 patients having recovered from the disease. Russia's latest data indicates 39,527 fatalities nationwide. Earlier, the Russian government set up an Internet hotline to keep the public updated on the coronavirus situation.